AMZN
Amazon.com, Inc.
AMZN has the edge over VNCE overall, supported by lower modeled downside and stronger valuation.
VNCE
Vince Holding Corp.
VNCE offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
VNCE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
VNCE's revenue, profitability, cash flow and balance sheet are all currently healthy.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over VNCE in the historical PE scenario, which offers more potential upside but is not a forecast.
VNCE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 1.2x | $0.70 | -95% |
| Fair | 8.6x | $4.91 | -62% |
| Expensive | 22x | $12.74 | -1.3% |
| Current | 23x | $12.91 | — |
Historical ranges are pointers, not guarantees.
VNCE's PE is in its expensive range at 23x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
VNCE Forward outlook
There aren't enough analyst estimates for VNCE to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over VNCE on earnings, with more consistent year-over-year improvement.
VNCE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.57 | +$1.92 |
| Q2 2026 | $0.70 | +$2.93 |
| Q1 2026 | $0.49 | +$2.00 |
| Q4 2025 | -$1.48 | -500% |
| Q3 2025 | -$1.35 | -1327% |
| Q2 2025 | -$2.23 | -192% |
| Q1 2025 | -$1.51 | -174% |
| Q4 2024 | $0.37 | -76% |
VNCE has returned to profit: it earned $0.57 per share over the past year, after losing money the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over VNCE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
VNCE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $81.8M | +12% |
| Q2 2026 | $64M | +11% |
| Q1 2026 | $83.7M | +4.7% |
| Q4 2025 | $85.1M | +6.2% |
| Q3 2025 | $73.2M | -1.3% |
| Q2 2025 | $57.9M | -2.1% |
| Q1 2025 | $80M | +6.2% |
| Q4 2024 | $80.2M | -4.7% |
VNCE's revenue is recovering but still below its 2020 peak: $82M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +1.3 points |
| Q2 2026 | -4.1% | +3.5 points |
| Q1 2026 | -3.5% | +34 points |
| Q4 2025 | 6.4% | -0.8 points |
| Q3 2025 | 15% | +14 points |
| Q2 2025 | -7.7% | -17 points |
| Q1 2025 | -37% | -35 points |
| Q4 2024 | 7.2% | +3.8 points |
VNCE has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
VNCE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $17.4M | +730% |
| Q2 2026 | -$9.1M | +$4.1M |
| Q1 2026 | $15.5M | -27% |
| Q4 2025 | -$5.7M | -211% |
| Q3 2025 | $2.1M | +$6M |
| Q2 2025 | -$13.2M | -$8.6M |
| Q1 2025 | $21.2M | +49% |
| Q4 2024 | $5.1M | -21% |
VNCE has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over VNCE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
VNCE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.7% | +343K shares |
| 1 year | +1.8% | +231K shares |
| 3 years | +5.7% | +710K shares |
| 5 years | +11% | +1.3M shares |
| Available history | +10% | +1.2M shares |
VNCE has 13M diluted shares, up 1.8% from a year ago.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
VNCE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 2.1x | Moderate |
| Q1 2026 | 1.6x | Healthy |
| Q4 2024 | 3.3x | Elevated |
| Q3 2024 | 4.4x | High |
| Q2 2024 | 1.1x | Healthy |
| Q1 2024 | 1.2x | Healthy |
| Q4 2023 | 1.7x | Healthy |
VNCE's net debt is less than a year of its operating earnings (EBITDA), down from 4.4 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
VNCE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.0 | Neutral |
| Stochastic | 80.2 | Overbought |
VNCE's weekly RSI is 67 (neutral) and its Stochastic is 80 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over VNCE on valuation relative to its sector.
VNCE PE vs Consumer Cyclical Sector
| Metric | VNCE | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 18x | 26% above |
| PE % | 85 | 47 | 38 pts above |
VNCE is trading at 23x earnings, a 26% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
VNCE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.8 | 9.7% above |
| 20 week MA | $8.76 | 47% above |
| 50 week MA | $5.72 | 126% above |
| 100 week MA | $4.03 | 220% above |
| 200 week MA | $3.58 | 261% above |
VNCE is in an uptrend: it's above all five of its weekly moving averages, and 261% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
VNCE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.7 | $5.26 | -70% |
| 2021 | $5.26 | $8.50 | +62% |
| 2022 | $8.50 | $7.72 | -9.2% |
| 2023 | $7.72 | $3.46 | -55% |
| 2024 | $3.46 | $4.02 | +16% |
| 2025 | $4.02 | $4.39 | +9.2% |
| 2026 YTD | $4.39 | $12.9 | +194% |
VNCE has the edge over AMZN on returns for 2026, with the stronger performance.